Sanara MedTech (SMTI)
(Delayed Data from NSDQ)
$27.90 USD
+0.82 (3.03%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $28.12 +0.22 (0.79%) 6:22 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Income Statements
Fiscal Year end for Sanara MedTech Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 65 | 46 | 24 | 16 | 12 |
Cost Of Goods | 8 | 6 | 2 | 2 | 1 |
Gross Profit | 57 | 39 | 22 | 14 | 11 |
Selling & Adminstrative & Depr. & Amort Expenses | 61 | 52 | 29 | 19 | 13 |
Income After Depreciation & Amortization | -4 | -12 | -7 | -5 | -3 |
Non-Operating Income | 0 | -1 | -1 | 1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -4 | -14 | -8 | -4 | -3 |
Income Taxes | 0 | -6 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4 | -8 | -8 | -4 | -3 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -4 | -8 | -8 | -4 | -3 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1 | -10 | -7 | -5 | -3 |
Depreciation & Amortization (Cash Flow) | 4 | 2 | 1 | 0 | 0 |
Income After Depreciation & Amortization | -4 | -12 | -7 | -5 | -3 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 8.28 | 7.91 | 7.34 | 5.74 | 2.13 |
Diluted EPS Before Non-Recurring Items | -0.57 | -1.00 | -1.08 | -0.76 | -1.32 |
Diluted Net EPS (GAAP) | -0.52 | -1.00 | -1.08 | -0.76 | -1.32 |
Fiscal Year end for Sanara MedTech Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 18.54 | 17.69 | 16.02 | 15.75 |
Cost Of Goods | NA | 1.89 | 1.79 | 1.75 | 2.19 |
Gross Profit | NA | 16.65 | 15.90 | 14.27 | 13.57 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 18.19 | 16.12 | 15.19 | 15.43 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.54 | -0.22 | -0.92 | -1.86 |
Non-Operating Income | NA | 0.00 | 0.25 | 0.00 | 0.00 |
Interest Expense | NA | 0.27 | 0.29 | 0.19 | 0.00 |
Pretax Income | NA | -1.80 | -0.26 | -1.09 | -1.87 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | -0.03 | -0.03 | -0.03 | -0.04 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.80 | -0.26 | -1.09 | -1.87 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.76 | -0.24 | -1.06 | -1.83 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 8.42 | 8.28 | 8.33 | 8.23 |
Diluted EPS Before Non-Recurring Items | NA | -0.21 | -0.03 | -0.13 | -0.22 |
Diluted Net EPS (GAAP) | NA | -0.21 | -0.03 | -0.13 | -0.22 |